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Findings From the AOSpine
Anticoagulation Global Initiative
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Philip Louie, MD3 , James Harrop, MD4, Thomas Mroz, MD5,
Khalid Al-Saleh, MBBS, FRCSC6, Giovanni Barbanti Brodano, MD7,
Jens Chapman, MD8, Michael G. Fehlings, MD, PhD9 , Serena S. Hu, MD10,
Yoshiharu Kawaguchi, MD, PhD11, Michael Mayer, MD12,
Venugopal Menon, MBBS, MS (Orth), MCh (Orth), MSc (Orth Eng)13 ,
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Marcelo Valacco, MD16, Luiz Vialle, MD, PhD17, Jeffrey C. Wang, MD18,
Karsten Wiechert, MD19, K. Daniel Riew, MD20,21, and Dino Samartzis, DSc1,2
Abstract
Study Design: Cross-sectional, international survey.
Objectives: To identify factors influencing pharmacologic anticoagulation initiation after spine surgery based on the AOSpine
Anticoagulation Global Survey.
Methods: This survey was distributed to the international membership of AOSpine (n ¼ 3805). A Likert-type scale described
grade practice-specific factors on a scale from low (1) to high (5) importance, and patient-specific factors a scale from low (0) to
high (3) importance. Analysis was performed to determine which factors were significant in the decision making surrounding the
initiation of pharmacologic anticoagulation.
Results: A total of 316 spine surgeons from 64 countries completed the survey. In terms of practice-specific factors considered
to initiate treatment, expert opinion was graded the highest (mean grade + SD ¼ 3.2 + 1.3), followed by fellowship training (3.2
+ 1.3). Conversely, previous studies (2.7 + 1.2) and unspecified guidelines were considered least important (2.6 + 1.6). Patient
body mass index (2.0 + 1.0) and postoperative mobilization (2.3 + 1.0) were deemed most important and graded highly overall.
Those who rated estimated blood loss with greater importance in anticoagulation initiation decision making were more likely to
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administer thromboprophylaxis at later times (hazard ratio [HR] ¼ 0.68-0.71), while those who rated drain output with greater
importance were likely to administer thromboprophylaxis at earlier times (HR ¼ 1.32-1.43).
Conclusion: Among our global cohort of spine surgeons, certain patient factors (ie, patient mobilization and body mass index)
and practice-specific factors (ie, expert opinion and fellowship training) were considered to be most important when considering
anticoagulation start times.
Keywords
timing, anticoagulation, antiplatelet, epidural hematoma, deep vein thrombosis, pulmonary embolism, initiation, pharmacologic
Introduction
Venous thromboembolism (VTE) is a preventable cause of
perioperative morbidity and mortality after spine surgery, with
a variable reported incidence of 0.3% to 31%.1-7 This wide
range of VTE after spine surgery can be explained by the
variation in indication for spine surgery, diverse patient popu-
lations, as well as lack of consistency in the method and timing
of diagnosis. Given the heterogeneity of medical comorbid-
ities, spinal pathology, and surgical techniques, a need for
patient-specific anti-coagulation guidelines is mounting.
Both pharmacologic and non-pharmacologic methods of
VTE prophylaxis are available after spine surgery. Early
patient mobilization, sequential compression devices (SCDs),
and compression stockings are common non-pharmacologic
approaches to VTE prophylaxis.4,8,9 Pharmacologic VTE pro-
phylaxis consists of agents that target platelet function or other
various points in the coagulation cascades.10-13 Examples of
such medications include aspirin, heparin, low-molecular-
weight heparin (LMWH), and warfarin. These agents can pro-
vide powerful prophylaxis against one potentially devastating
complication (VTE), but their use must be balanced against
equally significant adverse events, including epidural hema-
toma, excessive blood loss, and persistent wound drainage with
subsequent infection.14-16
There are currently no widely accepted global guidelines
regarding timing of initiation of perioperative VTE prophylaxis
for patients undergoing spine surgery. Although some studies
have made recommendations regarding timing of the start of
anti-coagulation and anti-platelet medications, as well as cre-
ated recommendations in patients undergoing spine surgery for
spinal cord injury, these have been limited by small sample
sizes that prevent extensive assessment of risk factors and het-
erogeneity among anti-coagulation methods.17-21 In 2009, the
North American Spine Society (NASS) released clinical guide-
lines based on the current body of evidence related to anti-
thrombotic therapies in spine surgery; however, thus far, these
have failed to capture input from a global perspective and have
yet to be adopted worldwide.12
Given the growing need for consensus surrounding recom-
mendations regarding perioperative anticoagulation manage-
ment in spine surgery, we conducted a global survey of spine
surgeons within the AOSpine network to gauge their knowl-
edge, attitudes and practices on this topic. Our preliminary
findings have been reported by Louie et al.22 With that serving
as a foundation, the specific focus of this study was to identify
factors that contribute to the decision making of the initiation
of anticoagulation after spine surgery among a global group of
spine surgeons. We hypothesized that the survey responses will
show heterogeneity in anticoagulation start times, with few




AOSpine Anticoagulation Global Survey methodology and
overall findings are detailed in Louie et al.22 In brief, a survey
questionnaire was developed and included surgeon demo-
graphics, rationale for anticoagulation following spine surgery,
risk stratification, the use of published/unpublished guidelines
to guide treatment, and the use of multidisciplinary teams. This
survey was distributed to the AOSpine membership that opted
to receive such requests via email (n ¼ 3805 members out of
approximately 6000 members).
The specific focus section assessed respondent demo-
graphics and perioperative factors that affect the timing of
anticoagulation prophylaxis based on medical comorbidities
and previous episodes of thrombosis and/or embolus. Survey
respondents were queried to grade the influence of various
practice-specific (fellowship training, expert opinion, previous
studies, unspecified guidelines) and perioperative specific con-
siderations (length of procedure, number of operative levels,
estimated blood loss [EBL], drain output, patient mobilization,
body mass index [BMI]) when making decisions regarding
anticoagulation initiation. Practitioners were asked to utilize
a Likert-type scale to grade practice-specific factors on a scale
from low (1) to high (5) importance, and patient-specific fac-
tors a scale from low (0) to high (3) importance.23
Respondents were then asked to report their postoperative
day of anticoagulation initiation in a series of hypothetical
patient scenarios. Twenty-five possible scenarios were
assessed and included patients who were either anticoagulation
naive or currently being medicated with aspirin, warfarin, or
another pharmacologic agent with or without a history of deep
venous thrombosis (DVT), pulmonary embolism (PE), atrial
fibrillation, coronary artery disease (CAD), placement of a
cardiac valve, or placement of a cardiac stent. For scenarios
where patients were taking pharmacologic anticoagulation,
2 Global Spine Journal
possible responses ranged from postoperative day 0 to beyond
postoperative day 5. For patients not previously taking antic-
oagulant medication, possible responses ranged from post-
operative day 0 to beyond postoperative day 7.
Statistical Analyses
All statistical analyses were performed with Stata version 13.1
(StataCorp LLC). Interpretation and categorization of all free-
response survey answers were made by one independent
reviewer to group similar categories for analyses. Calculation
of percentages and means was made for count data and rank-
order questions, respectively. Hypothetical patient scenarios
were further stratified to evaluate timing of thromboprophy-
laxis for history of specific conditions and individual medica-
tions, with survey responses right censored to the final
postoperative day response. Kaplan-Meier and log-rank test
analysis was used to assess individual variables for importance
in influencing timing to postoperative anticoagulation. All vari-
ables were then fitted to a series of Cox proportional hazards
models to further evaluate the hazard ratio (HR) and associated
P values and 95% confidence intervals (CIs) for each factor
considered. Higher HRs corresponded to earlier initiation of
anticoagulation. Model covariates included age, specialty, fel-
lowship, years since completion of fellowship training, geo-
graphic region, practice type (academic, private, combined),
annual practice case volume, and all queried practice-specific
(fellowship training, expert opinion, previous studies, unspeci-
fied guidelines, other specialty involvement) and
perioperative-specific considerations (procedure length, num-
ber of operative levels, EBL, drain output, patient mobilization,
and patient BMI). Proportional hazards assumptions were met
and validated using Schoenfeld residuals. The threshold for
statistical significance for all tests was established at P < .05.
Results
We have previously reported the initial findings from The
AOSpine Anticoagulation Global Survey regarding the demo-
graphics of the respondents.22 Briefly, 316 spine surgeons from
64 countries completed the survey (Table 1). When stratified
by continent, Europe had the largest survey representation
(31.7%), South America/Latin America (19.9%), and Asia
(18.4%). Respondents were between the ages of 35 and 44
(42.1%) or 45 to 54 (27.2%) years, and were typically
fellowship-trained (74.7%), and orthopedic surgeons (65.5%).
Most were within 5 years (26.4%) or 5 to 10 years (23.1%) of
completing their training, and practiced at academic (39.6%) or
combined private/academic institutions (46.2%). The vast
majority of respondents performed an estimated 101 to 200
cases per year (35.4%).
Regarding general practice-specific factors considered during
initiation of anticoagulation therapy, expert opinion was consid-
ered most important (mean grade + SD¼ 3.2 + 1.3), followed
by fellowship training (mean grade: 3.2; SD +1.3). Conversely,
previous studies (mean grade: 2.7; SD +1.2) and unspecified
guidelines were considered least important (mean grade: 2.6; SD
+1.6). For patient-specific factors, most variables considered
were graded with similar importance. Drain output (mean grade:
1.2; SD +1.0) and number of operative levels (mean grade: 1.2;
SD +1.0) were considered least important, followed by EBL
(mean grade: 1.2; SD +1.0) and procedure length (mean grade:
1.3; SD +1.1). Patient BMI (mean grade: 2.0; SD +1.0) and
postoperative mobilization (mean grade: 2.3; SD +1.0) were
deemed most important and graded highly overall. These results
are further illustrated in Table 2.
When accounting for multiple factors using a Cox propor-
tional hazards model approach, EBL and drain output were the
only factors significantly associated with the provided scenar-
ios that included both patient history (e.g. DVT, PE, CAD, etc)
as well as previous anticoagulant use (e.g. warfarin,
























North America 43 13.6
Europe 100 31.7
Asia 58 18.4
South America/Latin America 63 19.9
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acetylsalicylic acid [ASA], or other agent) (Table 3). These
variables demonstrated an inverse relationship with respect to
anti-coagulation timing. Those who rated EBL with greater
importance were likely to administer thromboprophylaxis at
later times, and those who rated drain output with greater
importance were likely to administer thromboprophylaxis at
earlier times. This was particularly true in scenarios with
patients with a history of DVT on warfarin (EBL: HR ¼
0.68, 95% CI ¼ 0.49-0.93, P ¼ .015; drain output: HR ¼
1.40, 95% CI ¼ 1.05-1.87, P ¼ .021), PE on ASA (EBL: HR
¼ 0.69, 95% CI ¼ 0.48-0.97, P ¼ .035; drain output: HR ¼
1.43, 95% CI ¼ 1.03-1.98, P ¼ .033), or CAD on ASA (EBL:
HR¼ 0.70, 95% CI¼ 0.50-0.96, P¼ .029; drain output: HR¼
1.36, 95% CI ¼ 1.02-1.81, P ¼ .034), or another unspecified
agent (EBL: HR ¼ 0.71, 95% CI ¼ 0.52-0.98, P ¼ .035; drain
output: HR ¼ 1.32, 95% CI ¼ 1.00-1.73, P ¼ .049).
These factors were also analyzed separately based on patient
history (Table 4) or previous anticoagulant used (Table 5). In the
setting of a history of DVT, EBL importance (HR ¼ 0.71, 95%
CI ¼ 0.50-1.00, P < .050) was associated with shorter time to
anticoagulation, while patient mobilization importance (HR ¼
1.40, 95% CI¼ 1.04-1.88, P¼ .029) was associated with longer
time to anticoagulation. EBL was the only factor associated with
an individual pharmacologic agent (previous warfarin use, HR¼
0.71, 95% CI¼ 0.50-0.99, P¼ .046). Factors were also analyzed
for scenarios where the patient was not previously on anticoa-
gulation. In this analysis, no factors were significantly associated
with the timing of anticoagulation (Table 6).
Discussion
Perioperative thromboprophylaxis usage and timing in spine
surgery remains a controversial topic given the lack of consen-
sus on optimal strategies. This area of perioperative
management remains challenging for surgeons given the het-
erogeneity in patient populations as well as various indications
for spine surgery. All strategies, unfortunately, weigh the risk
of clinically significant VTE versus early postoperative. With
no widespread acceptance, the timing of anticoagulation initia-
tion in the perioperative period of spine surgery can remain
challenging. To this end, we conducted the largest survey of
spine experts worldwide, and have identified several factors in
the decision making on the timing of initiation of perioperative
anticoagulation. The following were noted to be relative among
these spine experts: (1) patient mobilization and BMI are
important “patient-specific” factors when deciding initiation
of anticoagulation (without consideration of specific patient
presentations); (2) expert opinion and fellowship training were
the most substantial “practice-specific” factors, with formal
guidelines and studies considered less important; (3) when
accounting for multiple factors, opinions regarding the impor-
tance of EBL and drain output were associated with anticoa-
gulation initiation timing in numerous patient scenarios
involving both significant patient history (eg, DVT, PE, CAD,
etc) as well as previous anticoagulant use (eg, warfarin, ASA,
or other agent); and (4) opinions regarding the importance of
EBL and patient mobilization were associated with anticoagu-
lation timing in patients with a history of DVT.
The spine survey participants consensus was that their deci-
sions concerning anticoagulation therapy were more heavily on
expert opinion and fellowship training, rather than formal
guidelines or literature, in directing them regarding timing of
perioperative anti-coagulation. This highlights the lack of con-
sensus on timing of anticoagulant initiation in spine surgery.
Several survey studies have attempted to elucidate patterns
regarding anticoagulant use in spine surgery, although these
have been limited by geographic area, poor attention to timing
regarding anticoagulation, and lack of discernable patterns
driving decision making.18,19 In 2009, NASS released clinical
guidelines regarding antithrombotic therapies in spine sur-
gery.12 Although these guidelines address the question of tim-
ing of anticoagulation in the perioperative period by cautioning
surgeons to balance the risk of thromboembolic events with the
risk of epidural bleeding and wound complications, they do not
address the factors that should be considered, nor do they pro-
vide firm direction for decision making. Additionally, the lack
of a global perspective in the NASS guidelines weaken their
generalizability. In the preliminary findings from our survey
data, Louie and colleagues22 reported that only 14% of respon-
dents described following hospital, national, or other unspeci-
fied guidelines when deciding on the use of anticoagulation.
Despite this notion by our survey respondents, the AOSpine
group has released thromboprophylaxis guidelines for patients
suffering from spinal cord injury, which is the highest risk
group for VTE in patients undergoing spine surgery.20,21 All
in all, the existing literature, as well as our survey data recog-
nizes the lack of reliable data, as well as a failure to widely
disseminate existing guidelines.
When not involving patient scenarios specifically, our sur-
vey of surgeons found that patient mobilization and BMI are




General factors (out of 5, 5 ¼ high
importance)a
Fellowship training 3.2 1.3
Expert opinion 3.2 1.3
Studies 2.7 1.2
Guidelines 2.6 1.6
Patient-specific factors for initiation
(out of 3, 3 ¼ high importance)b
Length of procedure 1.3 1.1
Number of operative levels 1.2 1.0
Estimated blood loss 1.2 1.0
Drain output 1.2 1.0
Patient mobilization 2.3 1.0
Body mass index 2.0 1.0
a Mean ranking of importance for general factors was ordered from 1 to 5: 1 ¼
low importance, 5 ¼ high importance.
b Mean ranking of importance for specific factors was ordered from 0 to 3: 0 ¼
low importance, 3 ¼ high importance.






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































the most important patient-specific factors when considering
anticoagulation initiation. These opinions may be reflective of
the notion that patients who have high BMI or who may be
slow to mobilize in the perioperative period may be at higher
risk for VTE and may require earlier initiation of anticoagula-
tion. Identification of these risk factors for VTE in the perio-
perative period has been shown in previously reported
literature. Goz and associates3 created a VTE risk index based
on a review of 710 154 spinal fusions and included the presence
of obesity as a significant factor in predicting VTE. Pannucci
et al24 reviewed a Michigan statewide surgical quality colla-
borative to identify predictors of 90-day VTE in postsurgical
patients and found that among several other patient factors,
BMI greater than 40 kg/m2 was associated with higher risk of
VTE. McLynn and colleagues25 confirmed these findings in
their review of 109 609 patients from the National Surgical Qual-
ity Improvement Program (NSQIP) who underwent elective
spine surgery, finding that increased BMI was a risk factor for
VTE. Additionally, in a cohort of 1975 patients, Takahashi
et al26 reported a significantly lower symptomatic PE rate in
patients who had early mobilization after spine surgery, com-
pared to those patients who did not. To this end, the opinions
expressed by the surgeons in our survey study are consistent with
the current literature. Alternatively, some authors have linked
VTE to length of procedure, number of levels, and intraoperative
blood loss, although the respondents of our survey seemed to
give less importance to these specific factors.25,27
In several patient scenarios, opinions regarding the impor-
tance of EBL and drain output were associated with the timing
of anti-coagulation initiation in the perioperative periods.
Increased intraoperative blood loss may alert the surgeon to
an underlying or iatrogenic coagulopathy that may be exacer-
bated by the use of anticoagulants and/or antiplatelet medica-
tions. Awad et al28 reviewed the records of 14 932 patients
undergoing spine surgery and found that one of the risk factors
for the development of postoperative spinal epidural hematoma
included a high EBL (blood loss >1 L). Given this association
with the development of postoperative spinal hematoma, our
results show a prudent decision by spine experts to consider
EBL of importance when determining when to begin anticoa-
gulation. Similar to perioperative anti-coagulation manage-
ment in spine surgery, closed suction drains represent another
area of management where obvious consensus remains unes-
tablished. Several authors have found no difference in sympto-
matic postoperative hematoma or wound complications after
lumbar decompression and/or fusions with or without the use of
closed suction drains.28-32 In fact, Chimenti and Molinari33
reported that all four patients suffering from catastrophic epi-
dural hematoma (ie, neurologic deficit to American Spinal
Injury Association grade B or worse) in their series of 1750
patients had subfascial drains which failed to prevent this com-
plication. Other authors have disputed that drains do not play
an important role in preventing postoperative hematoma. Aono
et al34 reported the factors associated with the development of
Table 5. Cox Proportional Hazards Model for Perioperative Bridge Timing by Pharmacologic Agent Irrespective of Operative Location (Patient
Previously on Pharmacologic Agent).
ASA Warfarin Clopidogrel Other Any anticoagulant
HR 95% CI P HR 95% CI P HR 95% CI P HR 95% CI P HR 95% CI P
Respondent demographics
Age 0.90 0.57-1.41 .653 0.97 0.62-1.50 .875 0.95 0.61-1.48 .825 1.01 0.64-1.62 .954 1.46 0.43-4.93 .542
Specialty 1.33 0.85-2.09 .213 0.87 0.55-1.35 .527 0.81 0.54-1.22 .313 0.98 0.62-1.55 .932 1.70 0.56-5.14 .351
Fellowship trained 1.39 0.82-2.35 .222 0.92 0.57-1.49 .734 0.81 0.51-1.29 .379 0.72 0.43-1.20 .207 0.86 0.26-2.86 .801
Years posttraining 1.13 0.83-1.55 .435 0.98 0.73-1.32 .914 1.03 0.76-1.39 .849 0.92 0.67-1.26 .606 0.88 0.35-2.25 .796
Continent 1.04 0.86-1.25 .709 0.92 0.77-1.11 .404 0.97 0.81-1.16 .723 0.95 0.79-1.15 .613 1.06 0.70-1.61 .776
Practice type 0.89 0.69-1.16 .396 0.94 0.74-1.19 .598 0.88 0.70-1.12 .306 0.89 0.70-1.14 .368 0.81 0.46-1.45 .483
Volume 1.12 0.93-1.34 .221 1.04 0.87-1.24 .665 1.05 0.89-1.24 .589 1.11 0.94-1.32 .233 0.88 0.60-1.31 .538
General factors considered
Fellowship training 0.94 0.73-1.22 .655 0.98 0.76-1.25 .849 1.09 0.91-1.50 .491 1.05 0.81-1.36 .711 1.98 0.97-4.04 .060
Expert opinion 0.96 0.75-1.22 .728 0.85 0.67-1.08 .179 0.99 0.85-1.38 .933 0.95 0.74-1.21 .662 2.16 1.00-4.65 .050
Studies 1.14 0.88-1.48 .306 1.05 0.82-1.36 .681 1.17 0.79-1.24 .229 1.10 0.84-1.44 .494 1.88 0.88-4.02 .105
Guidelines 0.94 0.78-1.14 .517 0.95 0.79-1.14 .557 1.02 0.91-1.50 .860 0.98 0.81-1.18 .813 1.52 0.92-2.50 .099
Patient-specific factors for
initiation
Length of procedure 0.74 0.49-1.11 .142 0.84 0.58-1.22 .357 0.85 0.59-1.23 .392 0.91 0.62-1.34 .638 0.69 0.34-1.41 .306
Number of operative
levels
1.39 0.93-2.08 .111 1.16 0.78-1.70 .468 1.18 0.81-1.72 .395 1.16 0.79-1.72 .448 1.60 0.64-4.00 .315
Estimated blood loss 0.75 0.54-1.06 .102 0.71 0.50-0.99 .046 0.82 0.60-1.12 .219 0.81 0.58-1.14 .237 1.07 0.32-3.56 .916
Drain output 1.22 0.91-1.64 .178 1.25 0.93-1.67 .136 1.10 0.84-1.46 .485 1.27 0.93-1.74 .125 0.82 0.32-2.08 .677
Patient mobilization 1.26 0.93-1.73 .142 1.34 0.98-1.82 .067 1.32 0.98-1.77 .068 1.11 0.82-1.50 .492 1.30 0.58-2.90 .518
Body mass index 0.88 0.64-1.21 .433 0.82 0.60-1.13 .232 0.85 0.63-1.15 .300 0.85 0.62-1.16 .306 1.56 0.62-3.94 .344
Abbreviations: ASA, acetylsalicylic acid; HR, hazard ratio.
a Boldfaced values indicate statistical significance at P < .05.
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postoperative spinal epidural hematoma after surgery in their
series of 6356 patients, finding that over half of the hematomas
became symptomatic after closed suction drains were removed.
They suggested that removal of such drains was the key trigger
in a number of cases to allow the accumulation of hematoma to
the point of neurologic deficit. Additionally, Kao and associ-
ates35 found that drain output was significantly associated with
the development of symptomatic epidural hematoma post-
operatively (ie, patients with neurologic deficit were more
likely to have lower drain output). Although our survey did not
allow a detailed explanation as to the reasoning behind the
association between anticoagulation timing and drain output
among spine experts, this finding likely reflects the desire to
use drain output to guide anticoagulation initiation at a point
when epidural hematoma formation is unlikely. Literature is
unclear at this point whether the opinion held by our respon-
dents is a valid consideration in determining anticoagulation
timing.
This study is strengthened by the inclusion of numerous
patient scenarios that encompass the most common clinical
dilemmas regarding anticoagulation facing spine surgeons.
Although survey length limitations prevent an exhaustive list
of clinical scenarios, pharmacologic options, and patient fac-
tors, the data is comprehensive enough to provide some insight
into the decision making regarding anticoagulation initiation
timing. Additionally, this study is the largest of its kind, with a
global perspective that has not yet been described in the liter-
ature. This global perspective improves our findings’ general-
izability, and provides promise that studies utilizing our data
for follow-up explorations may be applicable to a wider
population.
There are a number of limitations to our study. First, this is a
survey study and limitations inherent to a study that does not
include empiric data exists. Additionally, questions were not
formatted in a way to allow the creation of specific guidelines.
Rather, this data will be utilized to create focal points that may
be useful in future follow-up survey studies, prospective, ran-
domized studies or Delphi-esque consensus statements. In
addition, survey distribution was limited to current spine sur-
geon members of the AOSpine network that opted-in to receive
email notifications, and as such, there is still questionable gen-
eralizability despite our large sample size. Finally, the survey
was sent out to 3805 spine surgeons worldwide with only 316
responses (8.3%). Although the response rate may appear low,
perhaps we have captured respondents who take special interest
in this topic and have placed greater thought to their anticoa-
gulation practices. Other authors have found that a low
response rate does not necessarily mean the study results have
low validity, although there is a greater risk of this; therefore,
low response rates should not be taken as an indicator of low
validity.36 Nonetheless, such a response rate is in line with
other previous surveys circulated to a mass membership, such
Table 6. Cox Proportional Hazards Model for Perioperative Anticoagulation Irrespective of Operative Location (Patient Not Previously on
Pharmacologic Agent).a
No prior Hx Hx of DVT
Hx of superficial
DVT Hx of CAD Hx of A-Fib
HR 95% CI P HR 95% CI P HR 95% CI P HR 95% CI P HR 95% CI P
Respondent demographics
Age 1.44 0.44-4.68 .548 1.37 0.60-3.13 .454 1.40 0.50-3.89 .521 1.30 0.52-3.23 .579 0.82 0.34-1.94 .645
Specialty 1.56 0.53-4.58 .423 1.73 0.79-3.76 .168 1.31 0.54-3.14 .551 1.89 0.83-4.29 .128 1.42 0.65-3.10 .375
Fellowship trained 0.85 0.26-2.75 .789 0.95 0.36-2.50 .918 0.87 0.33-2.28 .771 0.72 0.27-1.92 .516 1.34 0.48-3.71 .573
Years posttraining 0.90 0.36-2.28 .831 0.79 0.40-1.54 .481 0.83 0.35-1.94 .663 0.79 0.38-1.68 .547 1.28 0.63-2.60 .502
Continent 1.08 0.71-1.62 .725 0.91 0.61-1.36 .654 0.97 0.62-1.50 .874 0.92 0.63-1.34 .660 0.84 0.56-1.26 .397
Practice type 0.81 0.46-1.42 .459 0.84 0.51-1.37 .480 0.68 0.39-1.20 .183 0.96 0.56-1.63 .867 0.90 0.55-1.48 .677
Volume 0.89 0.61-1.31 .561 0.97 0.72-1.29 .814 0.96 0.69-1.34 .816 0.98 0.71-1.34 .893 1.03 0.76-1.40 .840
General factors considered
Fellowship training 1.76 0.89-3.49 .105 1.01 0.65-1.56 .958 1.17 0.69-2.00 .563 1.04 0.63-1.70 .887 1.10 0.68-1.78 .707
Expert opinion 1.94 0.92-4.07 .081 1.09 0.68-1.75 .713 1.34 0.74-2.40 .327 0.97 0.60-1.56 .901 1.16 0.74-1.84 .513
Studies 1.72 0.82-3.59 .151 1.22 0.76-1.94 .412 1.29 0.73-2.29 .386 1.42 0.85-2.37 .176 1.19 0.71-1.98 .512
Guidelines 1.38 0.85-2.23 .190 0.97 0.62-1.50 .888 1.00 0.61-1.65 .993 0.85 0.57-1.28 .440 0.98 0.67-1.43 .932
Patient-specific factors for
initiation
Length of procedure 0.74 0.38-1.43 .371 0.75 0.35-1.58 .447 0.68 0.30-1.52 .346 0.83 0.37-1.84 .640 0.70 0.35-1.42 .325
Number of operative
levels
1.56 0.63-3.87 .335 1.72 0.70-4.21 .237 1.64 0.63-4.27 .315 2.06 0.79-5.40 .140 1.83 0.78-4.26 .162
Estimated blood loss 1.04 0.32-3.41 .948 0.88 0.41-1.89 .744 0.90 0.39-2.07 .810 0.63 0.28-1.42 .261 0.84 0.38-1.82 .655
Drain output 0.82 0.32-2.07 .673 1.11 0.67-1.83 .692 1.05 0.59-1.89 .866 1.05 0.58-1.91 .868 1.03 0.58-1.82 .927
Patient mobilization 1.20 0.55-2.64 .652 1.04 0.53-2.02 .919 1.15 0.56-2.36 .712 1.21 0.61-2.42 .581 0.67 0.35-1.29 .231
Body mass index 1.52 0.63-3.70 .354 1.28 0.63-2.59 .490 1.35 0.60-3.05 .471 1.17 0.58-2.37 .654 1.75 0.87-3.56 .119
HX, history; DVT, deep venous thrombosis; CAD, coronary artery disease; A-Fib, atrial fibrillation; HR, hazard ratio.
a Boldfaced values indicate statistical significance at P < .05.
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as AOSpine. Although these limitations exist, our work
remains the largest, international survey to date focused on
perioperative anticoagulation practices during spine surgery.
Conclusions
This AOSpine Anticoagulation Global Survey is the largest to
date focusing on perioperative anticoagulation attitudes, prac-
tices, and beliefs among spine surgeons worldwide for VTE
prophylaxis. The survey noted certain patient factors (ie,
patient mobilization and BMI), certain practice-specific factors
(ie, expert opinion and fellowship training), and certain surgi-
cal factors (ie, EBL and drain output) when faced with specific
patient scenarios to be associated with decision making regard-
ing anticoagulation timing in the perioperative period.
Although certain areas of interest were identified in this survey
study, we encountered significant heterogeneity in practices
regarding decision making in timing of anticoagulation. Future
studies will utilize these findings to develop more robust pro-
spective studies to examine optimal anticoagulation timing in
the perioperative period and create consensus guidelines that
may more uniformly lead practice.
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